Interim analysis of STEVIE, a single-arm, open-label, multicentre study to evaluate the safety of the hedgehog pathway inhibitor vismodegib in patients with advanced basal cell carcinoma

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Lear J, Fife K, Gore M, Guerrero-Urbano T, Herd R, Plummer R, Seguin NB, Hansson J, Mitchell L, Starnawski M, Hauschild A

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: British Association of Dermatologists 94th Annual Meeting

Year of Conference: 2014

Pages: 3-3

Print publication date: 01/07/2014

ISSN: 1365-2133

Publisher: Wiley-Blackwell Publishing Ltd.

URL: http://dx.doi.org/10.1111/bjd.12928

DOI: 10.1111/bjd.12928

Series Title: British Journal of Dermatology

ePrints